Other posts

World Orphan Drug Congress USA 2026

From Tuesday through Thursday, our CEO, Geert Briers, will be attending the World Orphan Drug Congress USA 2026 in Boston.

As a trusted partner, Deltaclinical is committed to supporting the development of innovative therapies for rare diseases through high-quality clinical research services.

Attending the congress? Let’s connect and explore how we can accelerate your clinical development programs.

#Deltaclinical #DCT #WODCUSA #WODC #RareDiseases #OrphanDrugs #ClinicalResearch #DrugDevelopment #Biotech #Boston #Networkingcompassionate. Let’s keep pushing boundaries for those who need it most.

LinkedIn